Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems

Frontiers in Bioscience

Volumn 10, Issue 2, 2005, Pages 1779-1796

  Lai, Serene R ^a   Phipps, Sharla M O ^a   Liu, Liang ^a   Andrews, Lucy G ^a   Tollefsbol, Trygve O ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alternate lengthening of telomeres; Epigenetics; hTERT; p21; p53; Review; Senescence; Telomerase recruitment; Werner syndrome

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ALLELE; ARTICLE; GENE ACTIVITY; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; MOLECULAR EVOLUTION; MULTIGENE FAMILY; NONHUMAN; SEQUENCE HOMOLOGY; WILD TYPE;

ATAXIA; ATAXIA TELANGIECTASIA; EUKARYOTA;

EID: 17244369732     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1661     Document Type: Article

References (183)

1. Greider, C. W: Telomeres. Curr Opin Cell Biol 3, 3, 444-451 (1991)
2. Greider, C. W. and E. H. Blackburn: Telomeres, telomerase and cancer. Sci Am 274, 2, 92-97 (1996)
3. Greider, W., and E. H. Blackburn: Indentification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413 (1985)
4. Greider, C. W. and E. H. Blackburn: The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51, 887-898 (1987)
5. Greider, C. W. and E. H. Blackburn: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337, 6205, 331-337 (1989)
6. Meyerson, M., C. M. Counter, E. N. Eaton, L. W. Ellisen, P. Steiner, S. D. Caddle, L. Ziaugra, R. L. Baijersbergen, M. J. Davidoff, Q. Liu, S. Bacchetti, D. A. Haber and R. A. Weinberg: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells during immortalization. Cell 90, 785-795 (1997)
7. Nakamura, T., N. G. Morin, K. B. Chapman, R. L. Wienrich, W. H. Andrews, J. Lingner, C. B. Harley and T. R. Cech: Telomerase catalytic subunit homologs from fission yeast and humans. Science 277, 955-959 (1997)
8. Matsutomi, K., E. Y. Yu, S. Khurts, I. Ben-Porath, J. L. Currier, G. B. Metz, M. W. Brooks, S. Kaneko, S. Murakami, J. A. DeCaprio, R. A. Weinberg, S. A. Stewart and W. C. Hahn: Telomerase maintains telomere structure in normal human cells. Cell 114, 2, 241-253 (2003)
9. Yi,, X. V. M. Tesmer, I. Savre-Train, J. W. Shay and W. E. Wright: Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol 19, 3989-3997 (1999)
10. Li, M., Y. Wu, Y. R. Liang and X. Y. Wu: Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 9, 11, 2395-9 (2003)
11. Cong, Y-S., J. Wen and S. Bacchetti: Human telomerase and its regulation. MicroBiol Molec Biol Rev 66, 407-425 (1999)
12. Ducrest, A. L., H. Szutorisz, J. Lingner and M. Nabholz: Regulation of the human telomerase gene. Oncogene 21, 541-552 (2002)
13. Forsyth, N. R., W. E. Wright and J. W. Shay: Telomerase and differentiation in multicelluclar organisms: turn it off, turn it on, and turn it off again. Differentiation 69, 188-198 (2002)
14. Mason, P. J: Stem cells, telomerase and dyskeratosis congenital. Bioessays 25, 126-133 (2003)
15. Nakayama, J., H. Tahara, E. Tahara, M. Saito, K. Ito, H. Nakamura, T. Nakanishi, T. Ide and F. Ishikawa: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18, 65 68 (1998)
16. Vaziri H. and S. Benchimol: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Current Biol 8, 279-282 (1998)
17. Wright, W. E. and J. W. Shay: Two-step mechanism controlling cellular senescence and immortalization. Exp Geront 27, 383-389 (1992)
18. Bodnar, A. G., M. Cuellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. Harley, J. W. Shay, S. Lichtsteriner and S. E. Wright: Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998)
19. Funk, W. D., C. K. Wang, D. N. Shelton, C. B. Harley, G. D. Pagon and W. K. Hoeffler: Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp Cell Res 258, 2, 270-278 (2000)
20. Bryan, T. M., A. Englezou and L. Dalla-Pozza: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3, 1271-1274 (1997)
21. Saldanha, S. N., L. G. Andrews and T. O. Tollefsbol: Assessment of telomere length and factors that contribute to its stability. Eur J Biochem 270, 389-403 (2003)
22. Shay, J. W. and A. F. Gazdar: Telomerase in the early detection of cancer. J Clin Pathol 50, 106-109 (1997)
23. Bestor, T. H. and V. M. Ingram: Two DNA methyltransferases from murine erythro-leukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc Natl Acad Sci USA 80, 18, 5559-5563 (1983)
24. Gaudet, F., W. M. Rideout III, A. Meissner, J. Dausman, H. Leonhardt and R. Jaenisch: Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing. Mol Cell Biol 24, 4, 1640-1648 (2004)
25. Okano, M., D. W. Bell, D. A. Haber and E. Li: DNA methyltransferases Dnmt3a and Dnmt3b. Mol Cell Biol 19, 12, 8211-8218 (1999)
26. Guilleret, I., P. Yan, F. Grange, R. Braunschweig, F. T. Bosman and J. Benhattar: Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Can 101, 335-341 (2002)
27. Kitagawa, Y., S. Kyo, M. Takakura, T. Kanaya, K. Koshida, M. Namiki and M. Inoue: Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT. Clin Can Res 6, 7, 2868-2875 (2000)
28. Verreault, A.: De novo nucleosome assembly: new pieces in an old puzzle. Genes Dev 14, 12, 1430-1438 (2000)
29. Wood, A. and A. Shilatifard: Posttranslational modifications of histones by methylation. Adv Protein Chem 67, 201-222 (2004)
30. Kondo, Y. and J. P. Issa: Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells. J Biol Chem 278, 30, 27658-27662 (2003)
31. Rice, J. C., S. D. Briggs, B. Ueberheide, C. M. Barber, J. Shabanowitz, D. F. Hunt, Y. Shinkai and C. D. Allis: Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12, 6, 1591-1598 (2003)
32. Garcia-Cao, M., R. O'Sullivan, A. H. Peters, T. Jenuwein and M. A. Blasco: Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36, 1, 94-99 (2004)
33. Liu, L., S. N. Saldanha, M. S. Pate, L. G. Andrews and T. O. Tollefsbol: Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation. Genes Chromosomes Cancer 41, 1, 26-37 (2004)
34. Chuang, L. S., H. I. Ian, T. W. Koh, H. H. Ng, G. Xu and B. F. Li: Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 277, 5334, 1996-2000 (1997)
35. Fuks, F., W. A. Burgers, A. Brehm, L. Hughes-Davies and T. Kouzarides: DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 24, 1, 88-91 (2000)
36. Fuks, F., W. A. Burgers, N. Godin, M. Kasai and T. Kouzarides: Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 20, 10, 2536-2544 (2001)
37. Holt, S. E., W. E. Wright and J. W. Shay: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16, 6, 2932-2939 (1996)
38. Kondo, S., Y. Kondo, G. Li, R. H. Silverman and J. K. Cowell: Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16, 3323-3330 (1998)
39. Vogelstein, B., D. Lane and A. J. Levine: The p53 tumour-suppressor gene integrates numerous signals that control life and death. As when a highly connected node in the Internet breaks down, the disruption of p53 has severe consequences. Nature 408, 6810, 307-310 (2000)
40. Kanaya, T., S. Kyo, K. Hamada, M. Takakura, Y. Kitagawa, H Harada and M.Inoue: Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 6, 1239-1247 (2000)
41. WAF1/Cip1 gene by the p53 tumor suppressor protein. J Biol Chem 276, 31, 29116-29125 (2001)
42. Cip1/WAF1 in keratinocyte differentiation. J Biol Chem 272, 2, 1308-1304 (1997)
43. Young, J. I. and J. R. Smith: DNA Methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J Biol Chem 276, 22, 19610-19616 (2001)
44. Evans, R. J., F. S. Wyllie, D. Wynford-Thomas and C. J. Jones: A p53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development. Cancer Res 63, 16, 4854-4861 (2003)
45. Dotto, G. P: More than a break to the cell cycle? Biochim Biophys Acta 1471, M43-M56 (2000)
46. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi and D. Beach: p21 is a universal inhibitory of cyclin kinases. Nature 366, 6456, 634-5 (1993)
47. Harada, K., K. Kurisu, T. Sadatmoto, H. Tahara, E. Tahara, T. Ide and E. Tahara: Growth inhibition of human glioma cells by transfection-induced p21 and its effects on telomerase activity. J Neurooncol 47, 1, 39-46 (2000)
48. Hendersen, Y. C., R. L. Breau, T. J. Liu and G. L. Clayman: Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, E2F-1 genes by means of recombinant adenovirus. Head Neck 22, 4, 347-354 (2000)
49. WAF1 regulation. World J Gasenterol 8, 3, 400-405 (2002)
50. Nass, S. J., A. T. Ferguson, D. El-Ashry, W. G. Nelson and N. E. Davidson: Expression of DNA methyltransferase (DMT) and the cell cycle in human breast cancer cells. Oncogene 18, 7453-7461 (1999)
51. WAF1. Science 277, 1996-2000 (1997)
52. Cayrol, C., M. Knibiehler and B. Ducommun: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16, 3, 311-320 (1998)
53. Shats, I., M. Milyavsky, X. Tang, P. Stambolsky, N. Erez, R. Brosh, I. Kogan, I. Braunstein, M. Tzukerman, D. Ginsberg and V. Rotter: p53-dependent downregulation of telomerase is mediated by p21/waf1. J Biol Chem [Epub ahead of print] (2004)
54. Bailey, S. M., M. A. Brenneman and E. H. Goodwin: Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res 32, 12, 3743-3751 (2004)
55. Henson, J. D., A. A. Neumann, T. R. Yeager and R. R. Reddel: Alternate lengthening of telomeres in mammalian cells. Oncogene 21, 598-610 (2002)
56. Zaineb, R., R. Abdul, R. J. Varkonyi, M. Kulp-McEliece, C. Caslini, J. R. Testa, M. E. Murphy and D. Broccoli: p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance. Mol Cell Biol 24, 13, 5967-5977 (2004)
57. Bryan, T. M. and R. R. Reddel: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J Cancer 33, 767-773.
58. Yeager, T., A. Neumann, A. Englezou, L. Huschtscha, J. Noble and R. Reddel: Telomerase-negative immortalized human cells contain a novel type of Promyelocytic leukemia (PML) body. Cancer Res 59, 4175-4179 (1999)
59. Durham, M. A., A. A. Neymann, C. L. Fasching and R. R. Reddel: Telomere maintenance by recombination in human cells. Nat Genet 26, 447-450 (2000)
60. Cornforth, M. N. and R. L Eberle: Termini of human chromosomes display elevated rates of mitotic recombination. Mutagenesis 16, 85-89 (2001)
61. Smogorzewska, A., B. van Steensel, A. Bianchi, S. Oelmann, M. R. Schaefer, G. Schnapp and T. de Lange: Control of human telomere length by TRF1 and TRF2. Mol and Cell Biol 20, 5, 1659-1668 (2000)
62. Ohki, R. and F. Ishikawa: Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats. Nucleic Acids Res 32, 5, 1627-1637 (2004)
63. van Steensel, B. and T. de Lange: Control of telomere length by the human telomeric protein TRF1. Nature 385, 6618, 676-677 (1997)
64. Smogorzewska, A. and T. de Lange: Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73, 177-208 (2004)
65. Liu, D., A. Safari, M. S. O'Connor, D. W. Chan, A. Laegeler, J. Qin and Z. Songyang: PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol 6, 7, 673-680 (2004)
66. Ye, J. Z., D. Hockemeyer, A. N. Krutchinsky, D. Loayza, S. M. Hooper, B. T. Chait and T. de Lange: POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev 18, 4, 1649-1654 (2004)
67. Loayza, D. and T. de Lange: POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 6943, 926-927 (2003)
68. Loayza, D., H. Parsons, J. Donigian, K. Hoke and T. de Lange: DNA binding features of human POT1: a nonamer 5′-TAGGGTTAG-3′ minimal binding site, sequence specificity, and internal binding to multimeric sites. J Biol Chem 279, 13, 13241-13248 (2004)
69. Griffith, J. D., L. Comeau, S. Rosenfield, R. M. Stansel, A. Bianchi, H. Moss and T. de Lange: Mammalian telomeres end in a large duplex loop. Cell 97, 503-514 (1999)
70. Karlseder, J., A. Smogorzewska, T. de Lange: Senescence induced by altered telomere state, not telomere loss. Science 295, 5564, 2446-2449 (2002)
71. Li, B. and T. de Lange: Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell 14, 12, 5060-5068 (2003)
72. Snow, B. E., N. Erdmann, J. Cruickshank, H. Goldman, R. M. Gill, M. O. Robinson and L. Harrington: Functional conservation of the telomerase protein Est1p in humans. Curr Biol 13, 8, 698-704 (2003)
73. Reichenbach, P., M. Hoss, C. M. Azzalin, M. Nabholz, P. Bucher, J. Lingner: A human homolog of yeast Est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr Biol 13, 7, 568-574 (2003)
74. Kaminker, P. G., S-H. Kim, R. D. Taylor, Y. Zebarjadian, W. D. Funk, G. B. Morin, P. Yaswen and J. Campisi: TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J Biol Chem 276, 38, 35891-35899 (2001)
75. Smith, S., I. Giriat, A. Schmitt and T. de Lange: Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 5393, 1484-1487 (1998)
76. Kim, S-H., P. Kaminker and J. Campisi: TIN2, a new regulator of telomere length in human cells. Nat Genet 23, 4, 405-412 (1999)
77. Kim, S. H., C. Beausejour, A. R. Davalos, P. Kaminker, S. J. Heo and J. Campisi: TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem [Epub ahead of print] (2004)
78. Zhou, X. Z. and K. P. Lu: The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 107, 3, 347-359 (2001)
79. Lin, J. and E. H. Blackburn: Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA. Genes Dev 18, 4, 387-396 (2004)
80. Gershon, H. and D. Gershon: The budding yeast, saccharomyces cerevisiae, as a model for aging research: a critical review. Mech Aging Dev 120, 1-3, 1-22 (2000)
81. Guerin, J. C: Emerging area of aging research: long-lived animals with "negligible senescence." Ann NY Acad Sci 1019, 518-520 (2004)
82. Lutz, P. L., H. M. Prentice and S. L. Milton: Is turtle longevity linked to enhanced mechanisms for surviving brain anoxia and reoxygenation? Exp Gerontol 38, 7, 797-800 (2003)
83. Finch, C. E: Longevity, Senescence, and the Genome. Chicago University of Chicago Press (1990)
84. Cailliet, G. M., A. H. Andrews, E. J. Burton, D. L. Watters, D. E. Kline and L. A. Ferry-Graham: Age determination and validation studies of marine fishes: do deep-dwellers live longer? Exp Gerontol 36, 4-6, 739-764 (2001)
85. Holmes, D. J. and S. N, Austad: Birds as animal models for the comparative biology of aging: a prospectus. Journals of Gerontol 50A, B59-B66 (1995)
86. Holmes, D. J., R. Fluckiger and S. N. Austad: Comparative biology of aging in birds: an update. Exp Gerontol 36, 4-6, 869-883 (2001)
87. Rudolph, K. L., M. Millard, M. W. Bosenberg and R. A. DePinho: Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28, 2, 155-159 (2001)
88. Artandi, S. E., S. Alson, M. K. Tietze, N. E. Sharpless, S. Ye, R. A. Greenberg, D. H. Castrillon, J. W. Horner, S. R. Weiler, R. D. Carrasco, R. A. DePinho: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99, 12, 8191-8196 (2002)
89. Hayflick, L. and P. S. Moorhead: The serial cultivation of human diploid cell strains. Exp Cell Res 25, 585-621 (1961)
90. Hayflick, L: The cell biology of aging. Clin Geriatr Med 1, 1, 15-27 (1985)
91. Chiu, D. P. and C. B. Harley: Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 214, 99-106 (1997)
92. J. Campisi.Cancer, aging, and cellular senescence. In Vivo 14, 183-188 (2000)
93. Bodnar, G., M. Ouellette, M. Frolkis, S. E. Holt, C-P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner and W. E. Wright: Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998)
94. Harley, C. B: Telomere loss: molecular clock or genetic time bomb? Mutat Res 256, 271-282 (1991)
95. Blackburn, E. H: Telomere states and cell fates. Nature 408, 6808, 53-56 (2000)
96. Wright, W. E. and J. W. Shay: Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 6, 849-851 (2000)
97. Bryan, T. M. and R. R. Reddel: Telomere dynamics and telomerase activity in vitro immortalized human cells. Eur J Cancer 33, 767-773 (1997)
98. Serrano, M., A. W. Lin, M. E. Mccurrach, D. Beach and S. W. Lowe: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4A. Cell 88, 593-602 (1997)
99. Robles, S. J. and G. R. Adami: Agents that cause DNA double strand breaks lead to p16(INK4A) enrichment and the premature senescence of normal fibroblasts. Cell Cycle 16, 1113-1123 (1998)
100. Zhu, J., D. Woods, M. McMahon and J. M. Bishop: Senescence of human fibroblasts induced by oncongenic raf. Genes Dev 12, 2997-3007 (1998)
101. Busuttil, R. A., M. Dolle, J. Campisi and J. Vijg: Genomic instability, aging, and cellular senescence. Ann NY Acad. Sci 1019, 245-255 (2004)
102. Berube, N. G., J. R. Smith and O. M. Pereira-Smith: Insights from model systems: the genetics of cellular senescence. Am J Human Genet 62, 1015-1019 (1998)
103. Ogryzko, V. V., T. H. Hirai, V. R. Russanova, D. A. Barbie and B. H. Howard: Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 16, 5210-5218 (1996)
104. Sherwood, S. W., D. Rush, J. L. Ellsworth and R. T. Schimke RT: Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci USA 85, 23, 9086-9090 (1998)
105. Bayreuther, K., H. P. Rodemann, P. I. Francz PI and K. Maier: Differentiation of fibroblast stem cells. J Cell Sci Suppl 10, 115-130 (1988)
106. Bayreuther, K., H. P. Rodemann, R. Hommel, K. Dittmann, M. Albiez and P. I. Francz: Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci USA 85, 112-5116 (1988)
107. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj O. Pereira-Smith, and J. Campisi: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92, 20, 9363-9367 (1995)
108. T. Matsumura, Z. Zerrudo, L. Hayflick: Senescent human diploid cells in culture: survival, DNA synthesis and morphology. J Gerontol 34, 3, 328-334 (1999)
109. P. Dumont, M. Burton, Q. M. Chen, E. S. Gonos, C. Frippiat, J. B. Mazarati, F. Eliders, J. Remacle and O. Toussaint: Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblasts. Free Radical Biol Med 28, 3, 361-373 (2000)
110. Choi, H. S., Z. Lin, B. S. Li and A. Y. Liu: Age-dependent decrease in the heat-inducible DNA sequence-specific binding activity in human diploid fibroblasts. J Biol Chem 265, 29, 18005-18011 (1990)
111. Bonelli, M. A., R. R. Alfieri, P. G. Petronini, M. Bigotti, C. Campanini and A. F. Borghetti: Attenuated expression of 70-kDa heat shock protein in WI-38 human fibroblasts during aging in vitro. Exp Cell Res 252, 1, 20-32 (1999)
112. Seshadri, T. and J. Campisi: Repression of c-fos transcription and altered genetic program in senescent human fibroblasts. Science 247, 4939, 205-209 (1990)
113. Cristofalo, V. J., D. Volker, M. K. Francis and M. Tresini: Age-dependent modifications of gene expression in human fibroblasts. Crit Rev Eukaryot Gene Expr 8, 1, 43-80 (1998)
114. Kumazaki, T., R. S. Robetorye, S. C. Robetorye and J. R. Smith: Fibronectin expression increases during in vitro cellular senescence: correlation with increased cell area. Exp Cell Res 195, 1, 13-19 (1991)
115. Gonos, E. S., A. Derrentzi, M. Kreiborg, G. Agiostratidou, M. Kassem, B. F. Clark, P. S. Jat and S. I. Rattan: Cloning and identification of genes that associate with mammalian replicative senescence. Exp Cell Res 240, 1, 66-74 (1998)
116. Campisi, J: In: The molecular basis of cell cycle and growth control. Eds: G. S. Stein and R. Baserga, Wiley-Liss, NY 348-373 (1999)
117. Medawar, P. B: An Unsolved Problem of Biology. London: HK Lewis (1952)
118. Kinney, B. A., C. J. Miliska, R. W. Steger and A. Bartke: Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning memory parameters. Horm Behav 39, 277-284 (2001)
119. Hauck, S. J. and A. Bartke: Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase. Free Radic Biol Med 28, 970-978 (2001)
120. Enzi, G., M. Gasparo, R. R. Biondetti, D. Fiore, M. Semisa and F. Zurlo: Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography. Am J Clin Nutr 44, 739-746 (1986)
121. Merker, K., A. Stolzing and T. Grune: Proteolysis, caloric restriction and aging. Mech of Ageing and Dev 122, 595-615 (2001)
122. Harley, B. B., A. B. Futcher and C. W. Greider: Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990)
123. Slack, A., N. Cervoni, M. Pinard and M. Szyf: DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus, 40 large T antigen. J Biol Chem 274, 10105-10112 (1999)
124. Lopatina, N., J. F. Haskell, L. G. Andrews, J. C. Poole, S. Saldanha and T. Tollefsbol: Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem 84, 324-334 (2002)
125. Weindruch, R. and R. L. Walford: The Retardation of Aging and Disease by Dietary Restriction. IL, Thomas (1988)
126. Beckman, K. B. and B. N. Ames: The free radical theory of aging matures. Physiolol Rev 78, 2, 547-581 (1998)
127. Gensler, H. L. and H. Bernstein: DNA damage as the primary cause of aging. Q Rev Biol 56, 3, 279-303 (1981)
128. Schulz, V. P., V. A. Zakian, C. E. Ogburn: Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner Syndrome cells. Human Genet 97, 750-754 (1996)
129. Martin, J. A. and Buckwalter JA: Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol Biol Sci 56A, B172-B179 (2001)
130. Yang, L., T. Suwa, W. E. Wright, J. W. Shay and P. J. Hornsby: Telomere shortening and decline in replicative potential as a function of donor age in human adenocortical cells. Mech Ageing Dev 92, 190-194 (2001)
131. Paradis, V., N. Youssef, D. Dargere, N. Ba, F. Bonvoust, J. Deschatrette and P. Bedossa: Replicative senescence in normal liver, chronic hepatitic C, and hepatocellular carcinomas. Hum Pathol 32, 3, 327-332 (2001)
132. Going, J. J., R. C. Stuart, M. Downie, A. J. Fletcher-Monaghan and W. N. Keith: 'Senescence-associated' beta-galactosidase activity in the upper gastrointestinal tract. J Pathol 196, 4, 394-400 (2002)
133. Minamino, T., H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida and I. Komuro: Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105, 13, 1541-1544 (2002)
134. Castro, P., D. Giri, D. Lamb and M. Ittmann: Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55, 1, 30-38 (2003)
135. Price, J. S., J. G. Waters, C. Darrah, C. Pennington, D. R. Edwards, S. T. Donell and I. M. Clark. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1, 1, 57-65 (2002)
136. Campisi, J: Cellular senescence as a tumor-suppressor mechanism. TRENDS in Cell Biology 11, 11, S27-S31 (2001)
137. Verfaillie, C. M., M. F. Pera, and P. M. Lansdrop. Stem cells: hype and reality. Hematology 369-391 (2002)
138. Poole, J. C., L. G. Andrews and T. O. Tollefsbol: Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269, 1-2, 1-12 (2001)
139. Ahmed, A. and T. Tollefsbol: Telomeres and telomerase: basic science implications for aging. J Am Geriatr Soc 49, 8, 1105-1109 (2001)
140. Sperger, J. M, X. Chen, J. S. Draper, J. E. Antosiewicz, C. H. Chon, S. B. Jones, J. D. Brooks, P. W. Andrews, P. O. Brown and J. A. Thomson: Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci 100, 23, 13350-13355 (2003)
141. Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall and J. M. Jones: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998)
142. Leahy, J-W Xiong, F. Kuhnert and H. Stuhlmann: Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J Exp Zool 287, 67-81 (1999)
143. Yanai, J., T. Doetchman, N. Laufer, J. Maslaton, S. Mor-Yosef, A. Safran, M. Shani and D. Sofer: Embryonic cultures but not embryos transplanted to the mouse's brain grow rapidly without immunosuppression. Int J Neurosci 81, 1-2, 21-26 (1995)
144. Shamblott, M. J., J. Axelman, J. W. Littlefield, P. D. Blumenthal, G. R. H uggins, Y. Cui, L. Cheng and J. D. Gearhart: Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci 98, 1, 113-118 (2001)
145. Kremenskoy, M., Y. Kremenska, J. Ohgane, N. Hattori, S. Tanaka, K. Hashizume and K. Shiota: Genome-wide analysis of DNA methylation status of CpG islands in embryoid bodies, teratomas, and fetuses. Biochem. and Biophys. Res Comm 311, 884-890 (2003)
146. Guilleret, I., and J. Benhattar: Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 289, 2, 326-334 (2003)
147. Preston, S. L., M. R. Alison, S. J. Forbes, N. C. Direkze, R. Poulsom and N. A. Wright: The new stem cell biology: something for everyone. Mol Pathol 56, 86-96 (2003)
148. Zimmermann, S., M. Voss, S. Kaiser, U. Kapp, C. F. Waller and U. M. Martens: Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17, 6, 1146-1149 (2003)
149. Keith, W. N: From stem cells to cancer: balancing immortality and neoplasia. Oncogene 23, 29, 5092-5094 (2004)
150. Hong, W. K., R. E. Wittes, S. T. Hajdu, E. Cvitkovic, W. F. Whitmore and R. B. Golbey: The evolution of mature teratoma from malignant testicular tumors. Cancer 40, 2987-2992 (1977)
151. Ahmed, T., G. J. Bosl and S. I. Hajdu: Teratoma with malignant transformation in germ cell tumors in man. Cancer 56, 860-863 (1985)
152. Albanell, J., G. J. Bosl, V. E. Reuter, M. Engelhardt, S. Franco, M. A. S. Moore and E. Dmitrovsky: Telomerase activity in germ cell cancers and mature teratomas. J Nat Can Inst 91, 15, 1321-1326 (1999)
153. Lopatina, N. G., J. C. Poole, S. N. Saldanha, N. J. Hansen, J. S. Key, M. A. Pita, L. G. Andrews and T. O. Tollefsbol: Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem and Biophys Res Comm 306, 650-659 (2003)
154. Yamamoto, K., A. Imakiire, N. Miyagawa and T. Kasahara: A report of two cases of Werner's syndrome and review of the literature. J Orthopaedic Surgery 11, 2, 224-233 (2003)
155. Opresko, P. L., W-H. Cheng, C. von Kobbe, J. A. Harrigan and V. A. Bohr: Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis 24, 5, 791-802 (2003)
156. Yu, C.-E., J. Oshima, Y-H. Fu, E. M. Wijsman, F. Hisama, R. Alisch, S. Matthews, J. Nakura, T. Miki, S. Ouais, G. M. Martin, J. Mulligan and G. D. Schellenberg: Positional cloning of the Werner's syndrome gene. Science 272, 5259, 258-262 (1996)
157. Opresko, P. L., M. Otterlei, J. Graakjær, P. Bruheim, L. Dawut, S. Kølvraa, A. May, M. M. Seidman and V. A. Bohr: The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D Loops in a manner regulated by TRF1 and TRF2. Mol Cell Biol 14, 763-774 (2004)
158. Wyllie, B. S., C. J. Jones, J. W. Skinner, M. F. Haughton, C. Wallis, D. Wynford-Thomas, R. G. A. Faragher and D. Kipling: Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet 24, 1, 16-17 (2000)
159. Chang, S., A. S. Multani, N. G. Cabrera, M. L. Naylor, P. Laud, D. Lombard, S. Pathak, L. Guarente and R. A. DePinho: Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 36, 877-882 (2004)
160. Davis, T., S. K. Singhrao, F. S. Wyllie, M. F. Haughton, P. J. Smith, M. Wiltshire, D. Wynford-Thomas, C. J. Jones, R. G. A. Faragher and D. Kipling: Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J Cell Sci 116, 1349-1357 (2003)
161. Ahmed, A. and T. Tollefsbol: Telomeres, telomerase, and telomerase inhibition: clinical implications for cancer. J Am Geriatr Soc 51, 116-122 (2003)
162. Arai, T., Y. Yasuda, T. Takaya: Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid. Oncol Rep 5, 405-408 (1998)
163. Bednarek, A. K., A. Sahin, A.J. Brenner: Analysis of telomerase activity levels in breast cancer: positive detections at the in situ breast carcinoma stage. Clin Cancer Res 3, 11-16 (1997)
164. Ishibashi, K., K. Hirose, H. Kato: Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinomas. Anticancer Res 19, 2831-2836 (1999)
165. Orlando, C., S. Gelmini, C. Selli: Telomerase in urological malignancy. J Urol 166, 666-673 (2001)
166. Aogi, K., K. Kitahara, I. Buley: Telomerase activity in lesions of the thyroid: applications to diagnosis of clinical samples including fine-needle aspirates. Clin Cancer Res 4, 1965-1970 (1998)
167. Hiyama, B., T. Kodama, K. Shinbara: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57, 326-331 (1997)
168. Misawa, M., T. Tauchi, G. Sashida: Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol 21, 1087-1092 (2002)
169. Wong, S. C., H. Yu, S.M. Moochhala and J.B. So: Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells. Anticancer Res 23, 465-469 (2003)
170. Minev, B., J. Hipp, H. Firat: Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci USA 97, 4796-4801 (2000)
171. Liu, L., S. Lai, L.G. Andrews and T.O. Tollefsbol: Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 340, 1-10 (2004)
172. Feinberg, A. P. and B. Tycko: The history of cancer epigenetics. Nat Cancer 4, 143-153 (2004)
173. Bjornsson, H. T., M.D. Fallin and A.P. Feinberg: An integrated epigenetic and genetic approach to common human disease. TRENDS in Genetics 20, 8, 350-358 (2004)
174. Liu, L., S. N. Saldanha, M.S. Pate, L.G. Andrews and T.O. Tollefsbol: Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation. Genes Chromosomes and Cancer 41, 26-37 (2004)
175. Mutskov, V. and G. Felsenfeld: Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J 23, 138-149 (2004)
176. Marrone, A. and P.J. Mason: Dyskeratosis congenita. Cell Mol Life Sci 60, 3, 507-517 (2003)
177. Klapper, W., R. Parwaresch and G. Krupp: Telomere biology in human aging and aging syndromes. Mechanisms of Ageing and Development 122, 695-712 (2001)
178. Vessey, C. J., C.J Norbury and I. D. Hichson: Genetic disorders associated with cancer predisposition and genomic instability. Prog Nucl Acids Res Mol Biol 63, 189-221 (2000)
179. Leteurtre, F., X. Li, P. Guardiola: Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol 105, 883-893 (1999)
180. Okuda, K: Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis 152, 2, 391-398 (2000)
181. Chang, E. and C. B. Harley: Telomere length and replicative agingin in human vascular tissues. Proc Natl Acad Sci USA 92, 24, 11190-11194 (1995)
182. Wiemann S. U: Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16, 935-942 (2002)
183. Shu, H., W. Fu and M. P. Mattson: The catalytic subunit of telomerase protects neurons against amyloid - peptide-induced apoptosis. J Neurochem 75, 117-124 (2000)